Explore evidence

4.3 %Of 47 patients with type 1 diabetes, 2 (4.3%) had TPO autoantibodies.

Cameroundiabète de type 1 · TPO autoantibodiespublished 2006Clinical immunology (Orlando, Fla.)europe_pmcdocument of 10 observations

21.31 %The overall COVID-19 PCR-positivity rate was 21.31% among 291 participants.

CamerounCOVID-19observed November 2020 to July 2021published 2023VirusesOpenAlexdocument of 12 observationsDOI 10.3390/v15020407

15.1 %The prevalence of undernutrition in elderly patients with type 2 diabetes mellitus was 15.1% according to the GLIM criteria.

Cameroundiabète de type 2published 2024Nutritional Status of Elderly Patients with Type 2 Diabetes Mellitus: Case of a Regional Heurope_pmcdocument of 7 observationsDOI 10.21203/rs.3.rs-4047556/v1

143 participantsA total of 143 HIV-infected Cameroonians aged 21 years or above were recruited in the study.

CamerounVIH/sidapublished 2013Diabetes & metabolismeurope_pmcdocument of 12 observations

2.2 HbA1c_pointsNon-surgical periodontal treatment markedly improved glycaemic control with an attributable reduction of 2.2 points of HbA1c in poorly controlled T2D patients in a sub-Saharan setting.

Cameroundiabète de type 2published 2018BMC oral healtheurope_pmcdocument of 6 observations

82.4 %The prevalence of virological suppression was 82.4% overall among adult patients receiving antiretroviral therapy in the Centre and Littoral regions of Cameroon.

CamerounVIH/sidapublished 2019HIV medicineeurope_pmcdocument of 5 observationsDOI 10.1111/hiv.12681

25.2 %A total of 25.2% of participants were overweight yet metabolically healthy.

Camerounsyndrome métaboliqueobserved 1994published 2015Diabetology & metabolic syndromeeurope_pmcDOI 10.1186/s13098-015-0016-5

7.8 %Adult HIV prevalence (≥18 years) was 7.8% in 2011 (179/2,282 adults).

CamerounVIH/sidaobserved 2011published 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

1.3 %P. falciparum/P. ovale/P. malariae co-infections accounted for 1.3% of cases based on PCR results.

CamerounP. falciparum/P. ovale/P. malariaepublished 2023Parasites & vectorseurope_pmcdocument of 16 observationsDOI 10.1186/s13071-022-05635-7

74.3 %The FC27 allelic family prevalence was 74.3% in Mfou.

CamerounpaludismeHAL · Unilimdocument of 106 observations

23.6 %Among 407 patients on first-line antiretroviral treatment in rural Cameroon, 96 (23.6%) had unsuppressed viral load.

CamerounVIH/sidaobserved 2013-2014published 2016Open Forum Infectious Diseaseseurope_pmcdocument of 3 observations

108,000,000 inhabitantsThe number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014.

Cameroundiabète (non précisé)observed 1980published 2016Lancet (London, England)europe_pmcdocument of 7 observationsDOI 10.1016/s0140-6736(16)00618-8

0.43 SMDAmong HIV+ individuals, antiretroviral therapy use was associated with higher low-density lipoprotein with a standardized mean difference of 0.43.

Camerounlow-density lipoprotein · VIH/sidapublished 2013International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/dyt198

1 %If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is 1% for women.

Cameroundiabète (non précisé)observed 2025published 2016Lancet (London, England)europe_pmcdocument of 7 observationsDOI 10.1016/s0140-6736(16)00618-8

0.33 coefficientHoloTC was positively associated with the metabolic syndrome score in unadjusted analysis (coefficient 0.33, 95% CI: 0.10 to 0.56).

Camerounsyndrome métaboliquepublished 2021Nutrientseurope_pmcdocument of 9 observationsDOI 10.3390/nu14010178

12.3 %In the ANRS 12313 NAMSAL trial, the incidence of obesity over the first 48 weeks was 12.3% in the dolutegravir group versus 5.4% in the efavirenz group.

CamerounobésitéHAL · Unilimdocument of 25 observations

158 mmHgAfter one month of spironolactone treatment, office blood pressure in the spironolactone group decreased from 158 ± 17/86 ± 11 mmHg to 125 ± 11/72 ± 8 mmHg in Cameroonian type 2 diabetic patients with resistant hypertension.

Cameroundiabète de type 2 · resistant hypertensionpublished 2016BMC research noteseurope_pmcdocument of 5 observations

-1.18 mmHg_per_SD_differenceAn inverse association was observed between serum folate and diastolic blood pressure (−1.18, 95% CI: −2.16 to −0.20), unaffected by adjustment for confounders including PAEE and holoTC.

Camerouncardiometabolic diseasepublished 2021Current developments in nutritioneurope_pmcdocument of 6 observations

0.7 %The median 5-year cardiovascular risk was 0.7% according to the Framingham equation.

Camerounmaladies cardiovasculairespublished 2017BMJ openeurope_pmcdocument of 7 observations

53 per_1000La proportion de cas de paludisme confirmés (testés positifs) pour 1000 personnes par an était de 53 pour mille en 2013.

Camerounpaludismeobserved 2013HAL · Unilimdocument of 98 observations

6.6 unitsCapsaicin did not significantly reduce neuropathic pain in the intervention group after 8 weeks, with a mean pain intensity of 6.6±1.1 compared to 5.4±1.0 in the placebo group (p=0.55).

Cameroundiabetic peripheral neuropathypublished 2020The Efficacy of topical Capsaicin in the management of painful diabetic peripheral neuropaeurope_pmcdocument of 6 observationsDOI 10.21203/rs.3.rs-19190/v1

22 %The prevalence of overweight among males was 22.0% in Jamaica.

Camerounobésitépublished 2007Public health nutritioneurope_pmcdocument of 9 observationsDOI 10.1017/s1368980007246762

10.4 %Pretreatment HIV drug resistance (PDR) prevalence among all antiretroviral therapy (ART) initiators in Cameroon was 10.4% (95% CI 5.4%–19.1%).

CamerounVIH/sidaobserved 2015published 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument of 12 observationsDOI 10.1093/jac/dky221

7.3 %Borderline hypertension was detected in 7.3% of rural men in Cameroon.

Camerounborderline hypertensionpublished 1998International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/27.2.181

9.2 %The mean HbA1c was 9.2 ± 2.5%.

Cameroundiabète de type 1published 2019BMC research noteseurope_pmcdocument of 4 observationsDOI 10.1186/s13104-019-4054-1